Senior Scientist at Tabula Bio | CA, US | Rezi

Senior Scientist at Tabula Bio

Senior Scientist

Tabula Bio · CA, US

3 days ago

Senior Scientist

Tabula Bio · CA, US

3 days ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

Tabula is building an AI-first therapeutics company, starting with bacteriophages to design better therapies for hard-to-treat infections. This role is hands-on bench work in synthetic phage engineering, directly shaping the learning process within a company that integrates wet lab and computational efforts.

Responsibilities

  • Run core molecular biology and synthetic biology workflows related to phage engineering
  • Help construct, assemble, and test engineered phage variants
  • Execute host-phage assays and related experimental workflows with strong attention to data quality
  • Troubleshoot failures in constructs, assays, and protocols and improve them over time
  • Generate clean, useful experimental data that informs model development and research direction
  • Contribute to the growth of a small lab working on a technically ambitious problem with real-world consequences

Requirements

  • Recent, hands-on bench science experience
  • Enjoy building things in the lab
  • Care about experimental quality and can troubleshoot effectively
  • Excited by the idea of working on engineered living therapies
  • Desire for work to feed directly into a larger system combining wet-lab science and machine learning

Skills

  • Molecular biology
  • Synthetic biology
  • Phage engineering
  • Construct design and assembly
  • Cloning
  • Assay execution
  • Experimental troubleshooting
  • Data generation

Location

  • San Francisco Bay Area
  • Madison

Work Type

  • Hands-on bench role
  • Experimental
  • Collaborative

About the Company

  • Tabula is building an AI-first therapeutics company.
  • We are starting with bacteriophages, natural predators of bacteria, and building the models and experimental systems needed to design better therapies for hard-to-treat infections.
  • Antibiotic resistance is a serious and growing challenge, and new approaches are needed.
  • We think phages are one of the most interesting starting points.
  • The broader idea is bigger than phage therapy alone.
  • We believe drug discovery is going to become much more computational over time.
  • Tabula is being built around that belief from the beginning.
  • The wet lab is not separate from the computational work; it is a core part of the system.
  • We build models, generate data, test hypotheses, and improve the loop.
  • This role sits at an unusual intersection of synthetic biology, phage engineering, and machine learning.
  • The work is practical and technical, but it also points at a bigger idea: using computation to help design living systems that can treat disease.
  • We are still early, with room to shape how the work gets done and where it goes.